LOCAL ADVANCED OR METASTATIC NSCLC

Clinical trials for LOCAL ADVANCED OR METASTATIC NSCLC explained in plain language.

Never miss a new study

Get alerted when new LOCAL ADVANCED OR METASTATIC NSCLC trials appear

Sign up with your email to follow new studies for LOCAL ADVANCED OR METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo targets 'Undruggable' lung cancer mutation

Disease control Not yet recruiting

This study aims to test the effectiveness and safety of a new drug combination called goselasib for people with a specific type of advanced lung cancer (KRAS G12C mutation) who have not yet received treatment for their advanced disease. It will enroll about 69 adults to see how w…

Matched conditions: LOCAL ADVANCED OR METASTATIC NSCLC

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

LOCAL ADVANCED OR METASTATIC NSCLC

Get alerted when new LOCAL ADVANCED OR METASTATIC NSCLC trials appear

New drug combo targets 'Undruggable' lung cancer mutation